Qube Research & Technologies (QRT)
IDNA icon

Qube Research & Technologies (QRT)’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.57K Sell
295
-35
-11% -$1.02K ﹤0.01% 3344
2025
Q4 		$8.64K Buy
+330
New +$8.49K ﹤0.01% 3464
2022
Q3 		– Sell
-56
Closed -$2K – 2729
2022
Q2 		$2K Buy
+56
New +$1.67K ﹤0.01% 2382

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Qube Research & Technologies (QRT)'s IDNA Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 11% in Q1 2026, selling an estimated $1.02K and leaving 295 shares worth $8.57K. The position accounts for ﹤0.01% of the portfolio, ranked #3344.

Qube Research & Technologies (QRT) first reported a position in IDNA in Q2 2022 and has held it in 3 quarters since. The position peaked at $8.64K in Q4 2025. 60 funds tracked by Wall St. Rank hold IDNA as of Q1 2026.

  • Qube Research & Technologies (QRT) held 295 shares of iShares Genomics Immunology and Healthcare ETF worth $8.57K as of Q1 2026.
  • Qube Research & Technologies (QRT) sold 35 iShares Genomics Immunology and Healthcare ETF shares in Q1 2026, an estimated $1.02K.
  • iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #3344 holding.
  • Qube Research & Technologies (QRT) first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2022 and has held it in 3 quarters since.
  • Qube Research & Technologies (QRT)'s iShares Genomics Immunology and Healthcare ETF position peaked at $8.64K in Q4 2025.
  • 60 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.